Sat.Aug 17, 2024 - Fri.Aug 23, 2024

article thumbnail

The future of drug discovery: Using AI to optimise the hit-to-lead process

Drug Discovery World

Mirit Eldor , Managing Director, Life Sciences Solutions, Elsevier, looks at how artificial intelligence (AI) can improve the hit-to-lead process for small molecules. Early drug discovery takes an average of three-to-six years and accounts for 42% of total costs 1 in the development of a new drug. It’s therefore no surprise that pharmaceutical companies are increasingly interested in using artificial intelligence (AI) to accelerate development and reduce costs.

article thumbnail

Placebos reduce stress, anxiety, depression -- even when people know they are placebos

Science Daily: Pharmacology News

A study found that nondeceptive placebos, or placebos given with people fully knowing they are placebos, effectively manage stress -- even when the placebos are administered remotely.

141
141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling

Chemical Biology and Drug Design

TQ enhanced DOX sensitivity in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling. Abstract Natural compounds such as thymoquinone (TQ) have recently gained increasing attention in treating glioblastoma (GBM). However, the effects of TQ in reversing drug resistance are not completely understood. Therefore, we aimed to examine TQ impacts on GBM cells with doxorubicin (DOX) resistance and the involvement of the PI3K/Akt/mTOR pathway.

Treatment 100
article thumbnail

Wegovy Helps Patients With Heart Failure Avoid Heart Attack, Stroke

Drugs.com

FRIDAY, Aug. 23, 2024 -- Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart attacks and strokes, and now more data from the same trial suggests that's even true for very ill.

Trials 115
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New podcast: How technology is impacting drug discovery

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and The push towards lab automation in biopharma. In the first article, Andrew Radin, Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discov

Drugs 162
article thumbnail

Hydrogels can play Pong by 'remembering' previous patterns of electrical simulation

Science Daily: Pharmacology News

Non-living hydrogels can play the video game Pong and improve their gameplay with more experience, researchers report. The researchers hooked hydrogels up to a virtual game environment and then applied a feedback loop between the hydrogel's paddle -- encoded by the distribution of charged particles within the hydrogel -- and the ball's position -- encoded by electrical stimulation.

Research 141

More Trending

article thumbnail

A common fatty acid may help restore healthy vaginal bacteria after infection

Broad Institute

A common fatty acid may help restore healthy vaginal bacteria after infection By Ari Navetta August 19, 2024 Breadcrumb Home A common fatty acid may help restore healthy vaginal bacteria after infection Treatments using oleic acid, a naturally occurring oil used in cells, could improve treatment of recurrent bacterial vaginosis infections. By Ari Navetta August 19, 2024 Credit: Meilin Zhu Lactobacillus iners after treatment with oleic acid Related people Paul Blainey Related programs Metabolomi

Hospitals 121
article thumbnail

Breakthrough reveals new drug target for inflammatory diseases

Drug Discovery World

The discovery of a new regulator affecting immune cells could lead to new treatments to reduce inflammation in diseases including arthritis and severe Covid-19. A large research collaboration, led by the University of Exeter’s MRC Centre for Medical Mycology, has focused on how immune cells sense their environment. This activity triggers responses which are finely balanced, to protect against disease and infection, and to reduce cell-damaging inflammation.

Disease 162
article thumbnail

Mitochondria are flinging their DNA into our brain cells

Science Daily: Pharmacology News

A new study finds that mitochondria in our brain cells frequently fling their DNA into the cells' nucleus, where the mitochondrial DNA integrates into chromosomes, possibly causing harm.

DNA 136
article thumbnail

The Evolving Alzheimer’s Disease Landscape

Fierce BioTech

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries.

Disease 116
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Mounjaro, Zepbound Cut Odds for Diabetes by 94% in At-Risk People, Study Finds

Drugs.com

TUESDAY, Aug. 20, 2024 -- Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that an obese, prediabetic person will develop diabetes by 94%, a new trial shows. The three-year-long.

Trials 113
article thumbnail

This week in drug discovery (19-23 August) 

Drug Discovery World

News round-up for 19-23 August by DDW Senior Digital Content Editor Diana Spencer. It’s been a busy week for medical regulatory agencies, with a number of key decisions made on therapies for graft-versus-host-disease, neuroendocrine carcinoma, haemophilia B, lymphoma and non-small cell lung cancer. The top stories: FDA approves Niktimvo for chronic graft-versus-host disease The US Food and Drug Administration (FDA) has approved axatilimab-csfr (Niktimvo), a colony stimulating factor-1 receptor-b

article thumbnail

Life from a drop of rain: New research suggests rainwater helped form the first protocell walls

Science Daily: Pharmacology News

New research shows that rainwater could have helped create a meshy wall around protocells 3.8 billion years ago, a critical step in the transition from tiny beads of RNA to every bacterium, plant, animal, and human that ever lived.

RNA 130
article thumbnail

Updated COVID shots from Pfizer, Moderna cleared by FDA

BioPharma Drive: Drug Pricing

The approval of both reformulated messenger RNA vaccines, which are designed to target the KP.2 virus strain, comes just ahead of the fall and winter seasons.

RNA 110
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

FDA Approves Updated COVID Shots for Fall

Drugs.com

THURSDAY, Aug. 22, 2024 -- Updated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.This year's approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall.

article thumbnail

Treatment with antivirals improves liver outcomes in hepatitis C

Drug Discovery World

A new study from Korea University suggests that treatment with direct-acting antivirals (DAAs) improves liver disease-related clinical outcomes in patients with chronic hepatitis C virus (HCV) infection and reduces liver fibrosis-based disease burden. In recent years, DAAs that block replication of HCV have dramatically transformed the treatment of the disease, with around 90% effective anti-viral response rates.

Treatment 147
article thumbnail

Scientists discover new code governing gene activity

Science Daily: Pharmacology News

A newly discovered code within DNA -- coined 'spatial grammar' -- holds a key to understanding how gene activity is encoded in the human genome. This breakthrough finding revealed a long-postulated hidden spatial grammar embedded in DNA. The research could reshape scientists' understanding of gene regulation and how genetic variations may influence gene expression in development or disease.

article thumbnail

Perficient Named a 2024 Top Workplace in Atlanta

Perficient: Drug Development

We’re thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the Atlanta Journal-Constitution ! The Top Workplace award is a testament to our exceptional work environment and incredible company culture. Not to mention, this marks the second consecutive year we have received this honor. Winning a Top Workplace award is particularly meaningful as it is based solely on anonymous employee feedback.

Research 105
article thumbnail

Congo Says First Vaccines to Fight Mpox Arriving Next Week

Drugs.com

WEDNESDAY, Aug. 21, 2024 -- The first mpox vaccine doses from the United States are set to arrive next week in the Congo, the epicenter of an ongoing mpox outbreak in Africa.The doses come not a moment too soon: Just last week, the World Health.

Vaccine 107
article thumbnail

Semaglutide could also benefit patients with heart failure

Drug Discovery World

A new study indicates that anti-obesity drug semaglutide helps prevent cardiac events among overweight people who have cardiovascular disease, even if they also have heart failure. The results follow a previous finding that weekly injections of semaglutide were linked to a 20% reduction in major adverse cardiac events (MACE) such as heart attacks and strokes for people with obesity or who were overweight and had cardiovascular disease.

Disease 147
article thumbnail

Mosquitoes sense infrared from body heat to help track humans down

Science Daily: Pharmacology News

While a mosquito bite is often no more than a temporary bother, in many parts of the world it can be scary. One mosquito species, Aedes aegypti, spreads the viruses that cause over 100,000,000 cases of dengue, yellow fever, Zika and other diseases every year. Another, Anopheles gambiae, spreads the parasite that causes malaria. The World Health Organization estimates that malaria alone causes more than 400,000 deaths every year.

Virus 122
article thumbnail

BridgeBio sends rare disease drugs to new company

BioPharma Drive: Drug Pricing

Backed by $300 million from investors that include Viking Global Investors and Sequoia Capital, GondolaBio will inherit several BridgeBio drug programs.

Disease 111
article thumbnail

Government Report Links Excessive Fluoride in Water to Lowered IQs in Kids

Drugs.com

THURSDAY, Aug. 22, 2024 -- High levels of fluoride in drinking water may dim the intelligence of children, a new U.S. government report shows. Based on an analysis of published research, the potentially controversial report marks the first time a.

article thumbnail

Semaglutide found to increase risk of suicidal thoughts

Drug Discovery World

A new study has suggested a link between semaglutide (the active ingredient in Wegovy and Ozempic) and a disproportionately increased reporting of suicidality. Semaglutide has recently been treated as something of a wonder drug, with studies demonstrating it can reduce the risk of cardiovascular disease , stroke, and some cancers , and even suggesting it could treat addiction and neurodegenerative diseases.

article thumbnail

Bed-sharing has no impact on children's psychological development

Science Daily: Pharmacology News

Parental bed-sharing is unlikely to impact children's psychological development, new research has found. The study looked at nearly 17,000 British babies and tracked them for 11 years -- finding kids who shared beds were happy and healthy.

Research 119
article thumbnail

Lilly’s tirzepatide cuts diabetes risk, study data show

BioPharma Drive: Drug Pricing

Treatment with the GLP-1 drug, which Lilly sells as Mounjaro and Zepbound, lowered the risk of Type 2 diabetes progression by 94% versus placebo.

Treatment 110
article thumbnail

Therapeutic App Might Ease Anxiety in Young Adults

Drugs.com

WEDNESDAY, Aug. 21, 2024 -- It's not a replacement for actual psychotherapy, but a newly designed app could help young adults with mental health issues lower their anxiety, researchers report.The app, dubbed Maya, "can be an accessible and.

Research 107
article thumbnail

Talus raises $11.2M to target undruggable transcription factors

Drug Discovery World

Talus Bioscience has raised $11.2 million in new venture funding from a Seed+ round. The funding round was led by Two Bear Capital, with participation from WRF Capital, NFX, YC Continuity Fund, Funders Club VC, and BoxOne Ventures. The money will be invested to advance Talus Bio’s therapeutic programmes, which include Brachyury-driven cancers and an undruggable transcription factor implicated in prostate cancer.

DNA 147
article thumbnail

New gels could protect buildings during wildfires

Science Daily: Pharmacology News

Researchers have developed a sprayable gel that creates a shield to protect buildings from wildfire damage. It lasts longer and is more effective than existing commercial options.

Research 115
article thumbnail

Employers foresee higher health costs next year due to rising pharmacy spend

BioPharma Drive: Drug Pricing

Pharmaceuticals like the in-demand GLP-1 drugs for obesity are expected to drive increases in healthcare spending in 2025, per a new employer survey.

Pharmacy 105
article thumbnail

Universal Flu Vaccine Blocks Infection in Mice

Drugs.com

THURSDAY, Aug. 22, 2024 -- A universal flu vaccine that would protect against all influenza strains -- and that people might not need to take every year -- could be close at hand, researchers report.An experimental vaccine candidate produced a.

Vaccine 100
article thumbnail

Using gene therapy to live longer, healthier lives

Drug Discovery World

Sharon Rosenzweig-Lipson , PhD, is Chief Scientific Officer of Life Biosciences. She discusses with DDW’s Megan Thomas the company’s lead programme; a gene therapy called ER-100. Prolonging health span with drug development Life Biosciences aims to restore and prolong a patient’s health span by targeting the underlying biology of ageing and increasing the quality of years one spends in good health compared with just increasing the total number of years one lives.

Therapies 147
article thumbnail

Humpbacks are among animals who manufacture and wield tools

Science Daily: Pharmacology News

Researchers suggest a new designation of the humpback whales they study: tool wielders. Researchers have known that humpback whales create "bubble-nets" to hunt, but they have learned that the animals don't just create the bubble-nets; they manipulate this unique tool in a variety of ways to maximize their food intake in Alaskan feeding grounds.

Research 117
article thumbnail

As Bristol Myers’ schizophrenia drug nears approval, AbbVie and others hope to provide competition

BioPharma Drive: Drug Pricing

A new wave of antipsychotics could improve patient adherence. The race to corner this large projected market is already getting tight.

Marketing 113